ALL my I-Hub posts and post content are my opinions, views, thoughts, or beliefs ONLY! None of my posts are an endorsement to buy or sell any stock!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ERBB_NEEDS_TO_EXPLAIN_ALL_THE_NEGATIVES_GOING_ON_WITH_THE_COMPANY_IN_A_PR!!!
LIKE THIS ONE...
SORBYTECH'S 11-1-23 POST 340853: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173133234
I THINK MJ STOCKS+MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!
IN MY OPINION
MJNA HIT 22.2 CENTS_2021!!!
IN MY OPINION
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
MJNA HIT 22.2 CENTS_IN_2021!!!
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED 1/24/22 MJNA 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
WILL MJNA ENTER LEGAL MJ_MARKET_IF_MJ_BECOMES_LEGAL???
IN 2015, A PREVIOUS MJNA CEO INDICATED THEY COULD ENTER_LEGAL_MJ_MARKET_IF_MJ_BECOMES_LEGAL!!!
EXCERPT FROM "LETTER TO SHAREHOLDERS BY A PREVIOUS MJNA CEO STUART TITUS", 5/14/15, AS FOLLOWS:
"...we are poised and consider ourselves well-positioned for eventual cannabis legalization. We have a plan for that eventuality, and intend to leverage our relationships and expertise to help advance a truly legal cannabis industry when the day comes. Once legalization occurs or becomes better defined regarding states rights – we can quickly implement entry into this new market. Rescheduling – if not full de-scheduling – from the Controlled Substances Act would signal the clear demarcation point of our entry into the space."
SOURCE: http://medicalmarijuanainc.com/letter-to-shareholders-by-ceo-stuart-titus-2014-annual-report/
8-1-23 PR: MJNA's KANNAWAY DIV. COMPLETES_ACQUISTION_OF_KZ1_NETWORK_MARKETING_CO.!!!_https://finance.yahoo.com/news/medical-marijuana-inc-kannaway-division-130000811.html
EXCERPT BELOW FROM LINKED PR:
SAN DIEGO, August 01, 2023--(BUSINESS WIRE)--Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that its network marketing division, Kannaway, has completed an Asset Purchase Agreement with eXfuse, LLC, dba KZ1 a Japan based network marketing company. The KZ1 acquisition will increase the sales force of the Company’s Kannaway division in Japan by approximately 1,450 individuals and the Company believes the increased sales force will greatly benefit Kannaway’s ramp up in the Japanese market. KZ1’s premium product "Focus," containing Nootropics, which helps support cognitive function, has been well received in the Japanese market and adds to the Company’s current line of CBD, natural health and beauty products.
Commenting on the acquisition, Kannaway President Bill Andreoli stated: "The combining of these two companies’ products and distributor genealogies will have an immediate positive effect on revenue in Japan. I am so excited for Kannaway and KZ1 distributors coming together with such a strong message of Hemp & Wellness."
Tim Scott, CEO said, "We have worked hard to increase financial efficiency and increase cash flow and the acquisition of KZ1 fits right into this strategy. With this acquisition, combining the KZ1 sales force with Kannaway’s, we expect to see a strong impact in Japan. This is just another step in our strategy to grow through acquisitions while providing premium Hemp and Wellness products to our customers worldwide."
Under the asset purchase agreement Kannaway acquired essentially all of KZ1’s operating assets for a purchase price of $5 million and will integrate the KZ1 and Kannaway sales forces. Closing of the transaction required cash of $150,000 and conditional obligations to KZ1 totaling $4,850,000, which are payable only from royalties and sales overrides on future sales of KZ1 products and are otherwise non-recourse obligations against either Kannaway or the Company.
ABOUT MEDICAL MARIJUANA, INC.
Medical Marijuana, Inc. (OTCMarkets: MJNA) manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products via e-commerce, direct sales, retail and wholesale distribution channels throughout the world. The Company operates primarily through three divisions: Medical Marijuana, Inc., HempMeds®, and Kannaway®.
Medical Marijuana, Inc.
Medical Marijuana, Inc. is the parent company of all operating divisions and operates a website to maintain an online presence, provide corporate, investor relations and educational information and news relating to the Company and its operations.
HempMeds®
HempMeds® distributes CBD products directly in the US and through wholly owned subsidiaries internationally (primarily in Mexico and Brazil). Distribution is accomplished via its online presence and its sales staff.
Kannaway®
Kannaway® is the Company’s direct selling division which started in 2014 and was the first Cannabis based direct selling company. Kannaway is the Company’s largest division and sells the Company’s Natural Health and CBD products worldwide, including, but not limited to the US, Europe, and Asia. In September 2022, Kannaway purchased the assets of Mfinity Global LLC, a direct-selling organization focused on promoting Natural Health products. The Mfinity products have now been added to the Kannaway line of products.
ERBB_NEEDS_TO_EXPLAIN_ALL_THE_NEGATIVES_GOING_ON_WITH_THE_COMPANY_IN_A_PR!!!
LIKE THIS ONE...
SORBYTECH'S 11-1-23 POST 340853: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173133234
I THINK MJ STOCKS+MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!
IN MY OPINION
MJNA HIT 22.2 CENTS_2021!!!
IN MY OPINION
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
MJNA HIT 22.2 CENTS_IN_2021!!!
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED 1/24/22 MJNA 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
WILL MJNA ENTER LEGAL MJ_MARKET_IF_MJ_BECOMES_LEGAL???
IN 2015, A PREVIOUS MJNA CEO INDICATED THEY COULD ENTER_LEGAL_MJ_MARKET_IF_MJ_BECOMES_LEGAL!!!
EXCERPT FROM "LETTER TO SHAREHOLDERS BY A PREVIOUS MJNA CEO STUART TITUS", 5/14/15, AS FOLLOWS:
"...we are poised and consider ourselves well-positioned for eventual cannabis legalization. We have a plan for that eventuality, and intend to leverage our relationships and expertise to help advance a truly legal cannabis industry when the day comes. Once legalization occurs or becomes better defined regarding states rights – we can quickly implement entry into this new market. Rescheduling – if not full de-scheduling – from the Controlled Substances Act would signal the clear demarcation point of our entry into the space."
SOURCE: http://medicalmarijuanainc.com/letter-to-shareholders-by-ceo-stuart-titus-2014-annual-report/
8-1-23 PR: MJNA's KANNAWAY DIV. COMPLETES_ACQUISTION_OF_KZ1_NETWORK_MARKETING_CO.!!!_https://finance.yahoo.com/news/medical-marijuana-inc-kannaway-division-130000811.html
EXCERPT BELOW FROM LINKED PR:
SAN DIEGO, August 01, 2023--(BUSINESS WIRE)--Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that its network marketing division, Kannaway, has completed an Asset Purchase Agreement with eXfuse, LLC, dba KZ1 a Japan based network marketing company. The KZ1 acquisition will increase the sales force of the Company’s Kannaway division in Japan by approximately 1,450 individuals and the Company believes the increased sales force will greatly benefit Kannaway’s ramp up in the Japanese market. KZ1’s premium product "Focus," containing Nootropics, which helps support cognitive function, has been well received in the Japanese market and adds to the Company’s current line of CBD, natural health and beauty products.
Commenting on the acquisition, Kannaway President Bill Andreoli stated: "The combining of these two companies’ products and distributor genealogies will have an immediate positive effect on revenue in Japan. I am so excited for Kannaway and KZ1 distributors coming together with such a strong message of Hemp & Wellness."
Tim Scott, CEO said, "We have worked hard to increase financial efficiency and increase cash flow and the acquisition of KZ1 fits right into this strategy. With this acquisition, combining the KZ1 sales force with Kannaway’s, we expect to see a strong impact in Japan. This is just another step in our strategy to grow through acquisitions while providing premium Hemp and Wellness products to our customers worldwide."
Under the asset purchase agreement Kannaway acquired essentially all of KZ1’s operating assets for a purchase price of $5 million and will integrate the KZ1 and Kannaway sales forces. Closing of the transaction required cash of $150,000 and conditional obligations to KZ1 totaling $4,850,000, which are payable only from royalties and sales overrides on future sales of KZ1 products and are otherwise non-recourse obligations against either Kannaway or the Company.
ABOUT MEDICAL MARIJUANA, INC.
Medical Marijuana, Inc. (OTCMarkets: MJNA) manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products via e-commerce, direct sales, retail and wholesale distribution channels throughout the world. The Company operates primarily through three divisions: Medical Marijuana, Inc., HempMeds®, and Kannaway®.
Medical Marijuana, Inc.
Medical Marijuana, Inc. is the parent company of all operating divisions and operates a website to maintain an online presence, provide corporate, investor relations and educational information and news relating to the Company and its operations.
HempMeds®
HempMeds® distributes CBD products directly in the US and through wholly owned subsidiaries internationally (primarily in Mexico and Brazil). Distribution is accomplished via its online presence and its sales staff.
Kannaway®
Kannaway® is the Company’s direct selling division which started in 2014 and was the first Cannabis based direct selling company. Kannaway is the Company’s largest division and sells the Company’s Natural Health and CBD products worldwide, including, but not limited to the US, Europe, and Asia. In September 2022, Kannaway purchased the assets of Mfinity Global LLC, a direct-selling organization focused on promoting Natural Health products. The Mfinity products have now been added to the Kannaway line of products.
ERBB_NEEDS_TO_EXPLAIN_ALL_THE_NEGATIVES_GOING_ON_WITH_THE_COMPANY_IN_A_PR!!!
LIKE THIS ONE...
SORBYTECH'S 11-1-23 POST 340853: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173133234
I THINK MJ STOCKS+MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!
IN MY OPINION
MJNA HIT 22.2 CENTS_2021!!!
IN MY OPINION
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
MJNA HIT 22.2 CENTS_IN_2021!!!
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED 1/24/22 MJNA 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
WILL MJNA ENTER LEGAL MJ_MARKET_IF_MJ_BECOMES_LEGAL???
IN 2015, A PREVIOUS MJNA CEO INDICATED THEY COULD ENTER_LEGAL_MJ_MARKET_IF_MJ_BECOMES_LEGAL!!!
EXCERPT FROM "LETTER TO SHAREHOLDERS BY A PREVIOUS MJNA CEO STUART TITUS", 5/14/15, AS FOLLOWS:
"...we are poised and consider ourselves well-positioned for eventual cannabis legalization. We have a plan for that eventuality, and intend to leverage our relationships and expertise to help advance a truly legal cannabis industry when the day comes. Once legalization occurs or becomes better defined regarding states rights – we can quickly implement entry into this new market. Rescheduling – if not full de-scheduling – from the Controlled Substances Act would signal the clear demarcation point of our entry into the space."
SOURCE: http://medicalmarijuanainc.com/letter-to-shareholders-by-ceo-stuart-titus-2014-annual-report/
8-1-23 PR: MJNA's KANNAWAY DIV. COMPLETES_ACQUISTION_OF_KZ1_NETWORK_MARKETING_CO.!!!_https://finance.yahoo.com/news/medical-marijuana-inc-kannaway-division-130000811.html
EXCERPT BELOW FROM LINKED PR:
SAN DIEGO, August 01, 2023--(BUSINESS WIRE)--Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that its network marketing division, Kannaway, has completed an Asset Purchase Agreement with eXfuse, LLC, dba KZ1 a Japan based network marketing company. The KZ1 acquisition will increase the sales force of the Company’s Kannaway division in Japan by approximately 1,450 individuals and the Company believes the increased sales force will greatly benefit Kannaway’s ramp up in the Japanese market. KZ1’s premium product "Focus," containing Nootropics, which helps support cognitive function, has been well received in the Japanese market and adds to the Company’s current line of CBD, natural health and beauty products.
Commenting on the acquisition, Kannaway President Bill Andreoli stated: "The combining of these two companies’ products and distributor genealogies will have an immediate positive effect on revenue in Japan. I am so excited for Kannaway and KZ1 distributors coming together with such a strong message of Hemp & Wellness."
Tim Scott, CEO said, "We have worked hard to increase financial efficiency and increase cash flow and the acquisition of KZ1 fits right into this strategy. With this acquisition, combining the KZ1 sales force with Kannaway’s, we expect to see a strong impact in Japan. This is just another step in our strategy to grow through acquisitions while providing premium Hemp and Wellness products to our customers worldwide."
Under the asset purchase agreement Kannaway acquired essentially all of KZ1’s operating assets for a purchase price of $5 million and will integrate the KZ1 and Kannaway sales forces. Closing of the transaction required cash of $150,000 and conditional obligations to KZ1 totaling $4,850,000, which are payable only from royalties and sales overrides on future sales of KZ1 products and are otherwise non-recourse obligations against either Kannaway or the Company.
ABOUT MEDICAL MARIJUANA, INC.
Medical Marijuana, Inc. (OTCMarkets: MJNA) manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products via e-commerce, direct sales, retail and wholesale distribution channels throughout the world. The Company operates primarily through three divisions: Medical Marijuana, Inc., HempMeds®, and Kannaway®.
Medical Marijuana, Inc.
Medical Marijuana, Inc. is the parent company of all operating divisions and operates a website to maintain an online presence, provide corporate, investor relations and educational information and news relating to the Company and its operations.
HempMeds®
HempMeds® distributes CBD products directly in the US and through wholly owned subsidiaries internationally (primarily in Mexico and Brazil). Distribution is accomplished via its online presence and its sales staff.
Kannaway®
Kannaway® is the Company’s direct selling division which started in 2014 and was the first Cannabis based direct selling company. Kannaway is the Company’s largest division and sells the Company’s Natural Health and CBD products worldwide, including, but not limited to the US, Europe, and Asia. In September 2022, Kannaway purchased the assets of Mfinity Global LLC, a direct-selling organization focused on promoting Natural Health products. The Mfinity products have now been added to the Kannaway line of products.
ERBB_NEEDS_TO_EXPLAIN_ALL_THE_NEGATIVES_GOING_ON_WITH_THE_COMPANY_IN_A_PR!!!
LIKE THIS ONE...
SORBYTECH'S 11-1-23 POST 340853: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173133234
I THINK MJ STOCKS+MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!
IN MY OPINION
MJNA HIT 22.2 CENTS_2021!!!
IN MY OPINION
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
MJNA HIT 22.2 CENTS_IN_2021!!!
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED 1/24/22 MJNA 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
WILL MJNA ENTER LEGAL MJ_MARKET_IF_MJ_BECOMES_LEGAL???
IN 2015, A PREVIOUS MJNA CEO INDICATED THEY COULD ENTER_LEGAL_MJ_MARKET_IF_MJ_BECOMES_LEGAL!!!
EXCERPT FROM "LETTER TO SHAREHOLDERS BY A PREVIOUS MJNA CEO STUART TITUS", 5/14/15, AS FOLLOWS:
"...we are poised and consider ourselves well-positioned for eventual cannabis legalization. We have a plan for that eventuality, and intend to leverage our relationships and expertise to help advance a truly legal cannabis industry when the day comes. Once legalization occurs or becomes better defined regarding states rights – we can quickly implement entry into this new market. Rescheduling – if not full de-scheduling – from the Controlled Substances Act would signal the clear demarcation point of our entry into the space."
SOURCE: http://medicalmarijuanainc.com/letter-to-shareholders-by-ceo-stuart-titus-2014-annual-report/
8-1-23 PR: MJNA's KANNAWAY DIV. COMPLETES_ACQUISTION_OF_KZ1_NETWORK_MARKETING_CO.!!!_https://finance.yahoo.com/news/medical-marijuana-inc-kannaway-division-130000811.html
EXCERPT BELOW FROM LINKED PR:
SAN DIEGO, August 01, 2023--(BUSINESS WIRE)--Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that its network marketing division, Kannaway, has completed an Asset Purchase Agreement with eXfuse, LLC, dba KZ1 a Japan based network marketing company. The KZ1 acquisition will increase the sales force of the Company’s Kannaway division in Japan by approximately 1,450 individuals and the Company believes the increased sales force will greatly benefit Kannaway’s ramp up in the Japanese market. KZ1’s premium product "Focus," containing Nootropics, which helps support cognitive function, has been well received in the Japanese market and adds to the Company’s current line of CBD, natural health and beauty products.
Commenting on the acquisition, Kannaway President Bill Andreoli stated: "The combining of these two companies’ products and distributor genealogies will have an immediate positive effect on revenue in Japan. I am so excited for Kannaway and KZ1 distributors coming together with such a strong message of Hemp & Wellness."
Tim Scott, CEO said, "We have worked hard to increase financial efficiency and increase cash flow and the acquisition of KZ1 fits right into this strategy. With this acquisition, combining the KZ1 sales force with Kannaway’s, we expect to see a strong impact in Japan. This is just another step in our strategy to grow through acquisitions while providing premium Hemp and Wellness products to our customers worldwide."
Under the asset purchase agreement Kannaway acquired essentially all of KZ1’s operating assets for a purchase price of $5 million and will integrate the KZ1 and Kannaway sales forces. Closing of the transaction required cash of $150,000 and conditional obligations to KZ1 totaling $4,850,000, which are payable only from royalties and sales overrides on future sales of KZ1 products and are otherwise non-recourse obligations against either Kannaway or the Company.
ABOUT MEDICAL MARIJUANA, INC.
Medical Marijuana, Inc. (OTCMarkets: MJNA) manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products via e-commerce, direct sales, retail and wholesale distribution channels throughout the world. The Company operates primarily through three divisions: Medical Marijuana, Inc., HempMeds®, and Kannaway®.
Medical Marijuana, Inc.
Medical Marijuana, Inc. is the parent company of all operating divisions and operates a website to maintain an online presence, provide corporate, investor relations and educational information and news relating to the Company and its operations.
HempMeds®
HempMeds® distributes CBD products directly in the US and through wholly owned subsidiaries internationally (primarily in Mexico and Brazil). Distribution is accomplished via its online presence and its sales staff.
Kannaway®
Kannaway® is the Company’s direct selling division which started in 2014 and was the first Cannabis based direct selling company. Kannaway is the Company’s largest division and sells the Company’s Natural Health and CBD products worldwide, including, but not limited to the US, Europe, and Asia. In September 2022, Kannaway purchased the assets of Mfinity Global LLC, a direct-selling organization focused on promoting Natural Health products. The Mfinity products have now been added to the Kannaway line of products.
GOOD CATCH ON NPTX ERROR_IN_MY_POST_237039's_MJNA_ANNUAL_REPORT_EXCERPT!!! I JUST NOW CHECKED & ALL I COULD FIND WAS_A_WEBSITE_FOR_NEUROPATHIX, INC._https://neuropathix.com/ WITH A 2023 COPYRIGHT AT THE BOTTOM OF THE WEB PAGE, BUT, LIKE YOU, I COULD NOT FIND ANY INFO ON TICKER "NPTX" ANYWHERE!!!
MY YESTERDAY'S 11-2-23 MJNA POST 237039 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173147020, EXCEPT FOR THE POST HEADER, WAS A COPY AND PASTE EXCERPT FROM MJNAs ANNUAL REPORT FOR THE PERIOD ENDING 6/30/23 PUBLISHED/SIGNED ON 8/14/23: https://www.otcmarkets.com/otcapi/company/financial-report/379106/content https://www.otcmarkets.com/stock/MJNA/disclosure THE REPORT'S MJNA INVESTMENT NEUROPATHIX, INC. INFO WITH GIVEN TICKER "NPTX", THAT I EXCERPTED/INCLUDED IN MY POST, IS GIVEN ON PAGE 8.
THE NEW (AS OF MARCH 2023) MJNA CEO https://finance.yahoo.com/news/medical-marijuana-inc-appoints-ceo-130000182.html, AND MJNA CFO WHO SIGNED THE REPORT ON PAGE 14, NEEDS TO (1) CORRECT THAT "NPTX" ERROR, (2) VERIFY THAT NEUROPATHIX, INC. IS STILL AN MJNA INVESTMENT OR NOT, (3) VERIFY THAT EVERYTHING IN THE REPORT IS CORRECT, AND (4) ISSUE A CORRECTED REPORT.
NOW I'M WONDERING IF (1) NEUROPATHIX, INC. IS STILL AN MJNA INVESTMENT OR NOT AND (2) IF THERE ARE ANY OTHER ERRORS ON THE REPORT. HOPEFULLY, SOMEONE WILL (1) CALL MJNA INVESTOR RELATIONS, (2) LET THEM KNOW ABOUT THE "NPTX" ERROR, AND (3) TELL THEM TO VERIFY EVERYTHING ELSE IN THEIR REPORT AND ISSUE A CORRECTED REPORT.
ERBB_NEEDS_TO_EXPLAIN_ALL_THE_NEGATIVES_GOING_ON_WITH_THE_COMPANY_IN_A_PR!!!
LIKE THIS ONE...
SORBYTECH'S 11-1-23 POST 340853: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173133234
MJNAs_SUBSIDS,_PRODUCTS,_INVESTMENTS,_FACILITIES!!!
The Company operates primarily through three divisions: Medical Marijuana, Inc., HempMeds®, and Kannaway®. These divisions, as well as the Company’s investment portfolio, are discussed below.
MJNA AND SUBSIDIARY COMPANIES
1. Medical Marijuana, Inc.
Medical Marijuana, Inc. is the parent company of all the operating divisions. Medical Marijuana, Inc. operates a website to maintain an online presence, provide corporate, investor relations and educational information and news relating to the Company and its operations.
2. HempMeds®
HempMeds® distributes products directly in the US and through wholly owned subsidiaries internationally (primarily in Mexico and Brazil). Distribution is accomplished primarily through online presence and its sales staff.
The HempMeds® flagship product is Real Scientific® Hemp Oil (RSHO).® RSHO is a full spectrum, complete CBD hemp oil, containing the highest quality natural Hemp Oil in the industry. RSHO® is offered in 3 varieties: Green, Blue and Gold.
RSHO® Green is the non-decarboxylated, raw variety of our Real Scientific® Hemp Oil, and is as close as you can get to juicing the hemp plant.
RSHO® Blue is the most popular version of our CBD hemp oil products, going through a decarboxylation process before being made ready for consumption.
RSHO® Gold is decarboxylated like our Blue product, then goes through an additional filtration process, creating a golden oil with great taste and smoother consistency.
a. HempMeds® Mexico.
HempMeds® Mexico is the first Mexican cannabis company, established in 2016 with offices in México City and Monterrey. The HempMeds® Mexico products are the first-ever to be imported and commercialized legally in Mexico since 2016. With the reforms on the general health law (ley general de salud), HempMeds® Mexico is proud that its products were the first to be approved by the COFEPRIS (Federal Commission for Protection Against Health Risks) as food supplements and cosmetics in Mexico.
b. HempMeds® Brazil.
In Brazil, HempMeds® has three products approved for importation into Brazil as a prescription medication for multiple conditions including Epilepsy, Parkinson’s, Chronic Pain, Psoriasis, Cancer, Alzheimer’s, Diabetes, ALS, Multiple Sclerosis and Migraines. The Brazilian health care system is HempMeds® Brazil's single largest client. We had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, Medical Marijuana, Inc. | Disclosure Statement | June 30, 2023 Page 8 for the medical indications listed above. It is believed to also be the world’s first prescription cannabis product for Epilepsy, Parkinson's, and pain. HempMeds® Brazil is working on additional approvals for multiple indications.
3. Kannaway®
Kannaway® is our direct selling division which started in 2014 and was the first Cannabis based direct selling company. Kannaway is our largest division and sells our Natural Health and CBD products worldwide, including, but not limited to the US, Europe, and Asia.
In September 2022, Kannaway purchased the assets of Mfinity Global LLC, a direct-selling organization focused on promoting Natural Health products. Kannaway has now added the Mfinity products to the line of products that Kannaway sells. As part of the Mfinity transaction, Mfinity President, Bill Andreoli, became the President of Kannaway USA, LLC.
MANUFACTURING AND PRODUCTION FACILITY
The Company operates is manufacturing and production facility located in Vista, California. The facility is registered with the FDA, has been issued a Good Manufacturing Practice (GMP) certificate.
Our manufacturing facility provides small-to-large scale Manufacturing, Logistics, Bottle Filling, Kitting, Assembly, Warehousing and Storage for all the Company’s divisions except in Europe. The facility specializes in one-stop skin care, hair care and dietary supplement manufacturing and production services.
In addition to manufacturing our own products, our manufacturing facility offers White Label, private production services, and formulation and production of custom natural health and CBD products made to the customer’s unique specifications.
INVESTMENT PORTFOLIO
The Company’s investment portfolio consists of two public companies: Neuropathix, Inc. (formally known as Kannalife, Inc.) and AXIM Biotechnologies, Inc.
1. Neuropathix, Inc. (“Neuropathix”) (OTCBB: NPTX). Neuropathix is a socially responsible pain management life sciences company. For the past ten years, Neuropathix has discovered, developed and patented a global intellectual property estate of novel new therapeutic agents designed to prevent and reverse neuropathic pain, reduce oxidative stress, and act as anti-inflammatory neuroprotectants. Neuropathix was the only company to hold an exclusive license with National Institutes of Health - Office of Technology Transfer ("NIH-OTT") for the Commercialization of U.S. Patent #6630507, "Cannabinoids as Antioxidants and Neuroprotectants" (the "'507 Patent"). This early and extensive pre-clinical research on cannabidiol (CBD) led Neuropathix to develop its own patented molecules lead by KLS-13019 called by Sports Illustrated as a "super-CBD" and currently covered under global patents awarded including U.S. Patent #9611213, "Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy". Neuropathix continues to conduct its research and development efforts at the Bucks County Pennsylvania Biotechnology Center in Doylestown, PA. Neuropathix’s lead candidate KLS-13019 is a viable non-opioid solution for treating Chemotherapy Induced Peripheral Neuropathy ("CIPN"). It’s wholly owned subsidiary, Dermique Incorporated, now holds all the IP for LEA, its patented compound that is simply better than CBD for treating topical skin disorders. The Company currently owns approximately 23.4% of Neuropathix’s issued and outstanding shares of common stock.
2. AXIM® Biotechnologies, Inc., a Nevada corporation (“AXIM”) (OTCBB: AXIM). Founded in 2014, AXIM® is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Medical Marijuana, Inc. | Disclosure Statement | June 30, 2023 Page 9 Through the development of diagnostic solutions that quickly and accurately diagnose various diseases, AXIM’s products allow healthcare workers to quickly test and treat at the point-of-care, which leads to improved patient outcomes and provides numerous economic benefits to the healthcare system. Axim’s core competencies include development of rapid lateral flow immunoassays, reagents and monoclonal antibody development for such assays. AXIM’s current products fall into these categories: (i) Eye Health, wherein AXIM acquired two FDA cleared 510(k) tests for dye eye disease and has internally developed a third assay; (ii) SARS-CoV-2 neutralizing antibody tests; and (iii) A new fentanyl neutralizing antibody test in collaboration with new vaccines under development. Following the acquisition of two FDA cleared 510(k) tests for dye eye disease, AXIM’s product focus has been primarily in the area of Eye Health. AXIM continues to maintain the products and assays developed in connection with SARS-CoV-2 neutralizing antibody tests should a commercialization opportunity present itself in the future. AXIM is developing a new rapid diagnostic test to collaborate with leading universities to stop the deadly opioid crisis with new fentanyl vaccines. The Company currently: (i) owns approximately 10% of AXIM’s issued and outstanding shares of common stock; and (ii) holds a $4 million convertible note issued by AXIM which is convertible into an additional 53.8 million shares of AXIM's common stock.
MJNAs FACILITIES
We lease the following office and warehouse spaces:
17,819 square feet of mixed industrial space in Vista, California. The mixed space includes office, warehouse, manufacturing and distribution facilities. The lease commenced on December 1, 2022, and extends through until March 31, 3033. The total minimum lease payment is $3,100,506.
150 square meters of office space in Monterrey Mexico. The lease terminates in May 2024. Future minimum obligation on the lease totals 408,000 MXN (approximately $24,000 US Dollars).
Three (3) small office spaces in Sao Paolo, Brazil, consisting of 122 sq meters. The leases term runs through December 2023. Future minimum obligation on the leases totals 184,834 reais (approximately $37,644 US Dollars).
259 square meters of office space in Johannesburg, South Africa. The initial lease runs through November 30, 2023. Future minimum obligation on the lease totals $407,141 ZAR (approximately $21,610 US Dollars).
ABOVE IS EXCERPT FROM: https://www.otcmarkets.com/otcapi/company/financial-report/379106/content
8-1-23 PR: MJNA's KANNAWAY DIV. COMPLETES_ACQUISTION_OF_KZ1_NETWORK_MARKETING_CO.!!!_https://finance.yahoo.com/news/medical-marijuana-inc-kannaway-division-130000811.html
EXCERPT BELOW FROM LINKED PR:
SAN DIEGO, August 01, 2023--(BUSINESS WIRE)--Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that its network marketing division, Kannaway, has completed an Asset Purchase Agreement with eXfuse, LLC, dba KZ1 a Japan based network marketing company. The KZ1 acquisition will increase the sales force of the Company’s Kannaway division in Japan by approximately 1,450 individuals and the Company believes the increased sales force will greatly benefit Kannaway’s ramp up in the Japanese market. KZ1’s premium product "Focus," containing Nootropics, which helps support cognitive function, has been well received in the Japanese market and adds to the Company’s current line of CBD, natural health and beauty products.
Commenting on the acquisition, Kannaway President Bill Andreoli stated: "The combining of these two companies’ products and distributor genealogies will have an immediate positive effect on revenue in Japan. I am so excited for Kannaway and KZ1 distributors coming together with such a strong message of Hemp & Wellness."
Tim Scott, CEO said, "We have worked hard to increase financial efficiency and increase cash flow and the acquisition of KZ1 fits right into this strategy. With this acquisition, combining the KZ1 sales force with Kannaway’s, we expect to see a strong impact in Japan. This is just another step in our strategy to grow through acquisitions while providing premium Hemp and Wellness products to our customers worldwide."
Under the asset purchase agreement Kannaway acquired essentially all of KZ1’s operating assets for a purchase price of $5 million and will integrate the KZ1 and Kannaway sales forces. Closing of the transaction required cash of $150,000 and conditional obligations to KZ1 totaling $4,850,000, which are payable only from royalties and sales overrides on future sales of KZ1 products and are otherwise non-recourse obligations against either Kannaway or the Company.
ABOUT MEDICAL MARIJUANA, INC.
Medical Marijuana, Inc. (OTCMarkets: MJNA) manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products via e-commerce, direct sales, retail and wholesale distribution channels throughout the world. The Company operates primarily through three divisions: Medical Marijuana, Inc., HempMeds®, and Kannaway®.
Medical Marijuana, Inc.
Medical Marijuana, Inc. is the parent company of all operating divisions and operates a website to maintain an online presence, provide corporate, investor relations and educational information and news relating to the Company and its operations.
HempMeds®
HempMeds® distributes CBD products directly in the US and through wholly owned subsidiaries internationally (primarily in Mexico and Brazil). Distribution is accomplished via its online presence and its sales staff.
Kannaway®
Kannaway® is the Company’s direct selling division which started in 2014 and was the first Cannabis based direct selling company. Kannaway is the Company’s largest division and sells the Company’s Natural Health and CBD products worldwide, including, but not limited to the US, Europe, and Asia. In September 2022, Kannaway purchased the assets of Mfinity Global LLC, a direct-selling organization focused on promoting Natural Health products. The Mfinity products have now been added to the Kannaway line of products.
Nice GRPS 27% gain today!!!
SORBYTECH, THX FOR ALL_YOUR_ERBB_GREAT_DD/FINDINGS!!!...
LIKE THIS ONE...
I THINK MJ STOCKS+MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!
IN MY OPINION
MJNA HIT 22.2 CENTS_2021!!!
IN MY OPINION
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
10/16/23 FINS CONFIRMS ERBB SELLING_2325_CYPRESS_PROPERTY AS SORBYTECH FOUND OUT & POSTED ON 9/18/23!!! https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172848918
PER PAGES 10 & 18 OF THEIR 10/16/23 AMERICAN GREEN, INC. FINANCIAL REPORT: https://www.otcmarkets.com/otcapi/company/financial-report/383816/content
“If we are able to negotiate the removal of the lien and refinance the property, we have received offers to purchase it above $5M.”
HOWEVER, THEY MAY JUST LOSE THE PROPERTY ON 10/31/23 IN FORECLOSURE:
“The Company is attempting to refinance its property located at 2325 W. Cypress Street in Phoenix. Currently, the mortgage is in default and its contractor has placed a mechanics lien of approximately $2.2M dollars. The Company disputes the amount of the lien and is currently attempting to negotiate a settlement with removal of the lien as the primary reason to entertain a settlement. If we are unsuccessful, in obtaining the refinance, which is dependent upon achieving the release of the lien, we may lose the property on October 31, 2023, in foreclosure.”
BASED ON ALL THIS NEW “OFFICIAL” COMPANY INFO ABOVE, I WOULD “ASSUME” ALL CONSTRUCTION ON CONVERSION OF THE BUILDING IS NOW STOPPED SO ANY NEW/RECENT “PERMITS ISSUED” ON THE BUILDING CONSTRUCTION DO NOT MATTER ANY LONGER!!! https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172990832
BASED ON THE ABOVE, (1) AMERICAN GREEN, INCs ENDEAVOR TO HAVE A "SECOND" AMERICAN GREEN MJ CULTIVATION FACILITY HAS FAILED AND (2) THEY SHOULD HAVE NEVER ATTEMPTED TO DO THIS MONEY-LOSING ENDEAVOR.
ALSO, SORBYTECH FOUND OUT & POSTED ON 8/15/23 OTHER ERBB INFO AS WELL SPECIFICALLY ERBB SELLING THEIR “VENDWEB” VENDING MACHINE BUSINESS CONFIRMED ON PAGE 7 OF THEIR 10/16/23 ERBB FINANCIAL REPORT: “The Company is negotiating the sale of VendWeb, LLC.”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172606352
ADDITIONAL ERBB “NEGATIVES” IN ERBBs 10/16/23 ERBB FINANCIAL REPORT BELOW:
1. “The Company is currently in the process of applying for a 100:1 reverse stock split.” (PAGE 2)
2. “The Company has been sued by a leasing company over approximately $900,000 in equipment for our Cypress facility. The Company is negotiating the sale of that equipment and hopes to settle the suit with the proceeds of this proposed sale”. (PAGES 10 & 18)
3. “The Company has been sued by Glorious Extracts over the termination of its rental of space at our Virginia Grow. WE believe that we had more than sufficient grounds to terminate their presence in our facility. Settlement discussions continue”. (PAGES 10 & 18)
ERBB SHOULD HAVE BEEN INFORMING/UPDATING/WARNING ERBB SHAREHOLDERS, POTENTIAL SHAREHOLDERS, AND OTHERS OF THEIR SERIOUS “NEGATIVE” ERBB UNEXPECTED “TURN OF EVENTS” FREQUENTLY IN PRs SINCE THEIR LAST PR OVER “EIGHT” MONTHS AGO ON 2/14/23 SO PEOPLE DO NOT (1) “ASSUME” THINGS ARE GOING AS PLANNED AND (2) GET A “BIG NEGATIVE SURPRISE” GETTING NOTIFIED IN THEIR AMERICAN GREEN, INC. FINANCIAL REPORT “EIGHT” MONTHS AFTER THEIR 2/14/23 PR!!!
ERBB STILL NEEDS TO ISSUE A PR NOTING AND EXPLAINING ALL THE ABOVE; ANY OTHER COMPANY CONCERNS; AND THE COMPANY’S FUTURE OUTLOOK!!! ERBB SHOULD HAVE ISSUED THEIR 10/16/23 FINANCIAL REPORT IN A PR!!!
>>>CHECK OUT SORBYTECH'S POSTS FOR ANY OF HIS ADDITIONAL ERBB DD/FINDINGS: https://investorshub.advfn.com/boards/profile.aspx?user=686285
ERBB HAS NOT ISSUED A PR IN_8.5_MONTHS_SINCE_2/14/23!!!...
10/16/23 FINS CONFIRMS ERBB SELLING_2325_CYPRESS_PROPERTY AS SORBYTECH FOUND OUT & POSTED ON 9/18/23!!! https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172848918
PER PAGES 10 & 18 OF THEIR 10/16/23 AMERICAN GREEN, INC. FINANCIAL REPORT: https://www.otcmarkets.com/otcapi/company/financial-report/383816/content
“If we are able to negotiate the removal of the lien and refinance the property, we have received offers to purchase it above $5M.”
HOWEVER, THEY MAY JUST LOSE THE PROPERTY ON 10/31/23 IN FORECLOSURE:
“The Company is attempting to refinance its property located at 2325 W. Cypress Street in Phoenix. Currently, the mortgage is in default and its contractor has placed a mechanics lien of approximately $2.2M dollars. The Company disputes the amount of the lien and is currently attempting to negotiate a settlement with removal of the lien as the primary reason to entertain a settlement. If we are unsuccessful, in obtaining the refinance, which is dependent upon achieving the release of the lien, we may lose the property on October 31, 2023, in foreclosure.”
BASED ON ALL THIS NEW “OFFICIAL” COMPANY INFO ABOVE, I WOULD “ASSUME” ALL CONSTRUCTION ON CONVERSION OF THE BUILDING IS NOW STOPPED SO ANY NEW/RECENT “PERMITS ISSUED” ON THE BUILDING CONSTRUCTION DO NOT MATTER ANY LONGER!!! https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172990832
BASED ON THE ABOVE, (1) AMERICAN GREEN, INCs ENDEAVOR TO HAVE A "SECOND" AMERICAN GREEN MJ CULTIVATION FACILITY HAS FAILED AND (2) THEY SHOULD HAVE NEVER ATTEMPTED TO DO THIS MONEY-LOSING ENDEAVOR.
ALSO, SORBYTECH FOUND OUT & POSTED ON 8/15/23 OTHER ERBB INFO AS WELL SPECIFICALLY ERBB SELLING THEIR “VENDWEB” VENDING MACHINE BUSINESS CONFIRMED ON PAGE 7 OF THEIR 10/16/23 ERBB FINANCIAL REPORT: “The Company is negotiating the sale of VendWeb, LLC.”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172606352
ADDITIONAL ERBB “NEGATIVES” IN ERBBs 10/16/23 ERBB FINANCIAL REPORT BELOW:
1. “The Company is currently in the process of applying for a 100:1 reverse stock split.” (PAGE 2)
2. “The Company has been sued by a leasing company over approximately $900,000 in equipment for our Cypress facility. The Company is negotiating the sale of that equipment and hopes to settle the suit with the proceeds of this proposed sale”. (PAGES 10 & 18)
3. “The Company has been sued by Glorious Extracts over the termination of its rental of space at our Virginia Grow. WE believe that we had more than sufficient grounds to terminate their presence in our facility. Settlement discussions continue”. (PAGES 10 & 18)
ERBB SHOULD HAVE BEEN INFORMING/UPDATING/WARNING ERBB SHAREHOLDERS, POTENTIAL SHAREHOLDERS, AND OTHERS OF THEIR SERIOUS “NEGATIVE” ERBB UNEXPECTED “TURN OF EVENTS” FREQUENTLY IN PRs SINCE THEIR LAST PR OVER “EIGHT” MONTHS AGO ON 2/14/23 SO PEOPLE DO NOT (1) “ASSUME” THINGS ARE GOING AS PLANNED AND (2) GET A “BIG NEGATIVE SURPRISE” GETTING NOTIFIED IN THEIR AMERICAN GREEN, INC. FINANCIAL REPORT “EIGHT” MONTHS AFTER THEIR 2/14/23 PR!!!
ERBB STILL NEEDS TO ISSUE A PR NOTING AND EXPLAINING ALL THE ABOVE; ANY OTHER COMPANY CONCERNS; AND THE COMPANY’S FUTURE OUTLOOK!!! ERBB SHOULD HAVE ISSUED THEIR 10/16/23 FINANCIAL REPORT IN A PR!!!
>>>CHECK OUT SORBYTECH'S POSTS FOR ANY OF HIS ADDITIONAL ERBB DD/FINDINGS: https://investorshub.advfn.com/boards/profile.aspx?user=686285
WILL MJNA ENTER LEGAL MJ_MARKET_IF_MJ_BECOMES_LEGAL???
IN 2015, A PREVIOUS MJNA CEO INDICATED THEY COULD ENTER_LEGAL_MJ_MARKET_IF_MJ_BECOMES_LEGAL!!!
EXCERPT FROM "LETTER TO SHAREHOLDERS BY A PREVIOUS MJNA CEO STUART TITUS", 5/14/15, AS FOLLOWS:
"...we are poised and consider ourselves well-positioned for eventual cannabis legalization. We have a plan for that eventuality, and intend to leverage our relationships and expertise to help advance a truly legal cannabis industry when the day comes. Once legalization occurs or becomes better defined regarding states rights – we can quickly implement entry into this new market. Rescheduling – if not full de-scheduling – from the Controlled Substances Act would signal the clear demarcation point of our entry into the space."
SOURCE: http://medicalmarijuanainc.com/letter-to-shareholders-by-ceo-stuart-titus-2014-annual-report/
PER SORBYTECH'S POST, ERBB IS_NOW_"PINK_LIMITED_INFORMATION"_https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173133234
MJNA HIT 22.2 CENTS_IN_2021!!!
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED 1/24/22 MJNA 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
NOT GOOD!!! ERBB_NEEDS_TO_EXPLAIN_ALL_THE_NEGATIVES_GOING_ON_WITH_THE_COMPANY_IN_A_PR!!!
REPLIED-TO POST QUOTE BELOW:
I THINK MJ STOCKS+MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!
IN MY OPINION
MJNA HIT 22.2 CENTS_2021!!!
IN MY OPINION
*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!
MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!
MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****
LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical
.268/.0275 = 9.75 TIMES!!!...
SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical
8-1-23 PR: MJNA's KANNAWAY DIV. COMPLETES_ACQUISTION_OF_KZ1_NETWORK_MARKETING_CO.!!!_https://finance.yahoo.com/news/medical-marijuana-inc-kannaway-division-130000811.html
EXCERPT BELOW FROM LINKED PR:
SAN DIEGO, August 01, 2023--(BUSINESS WIRE)--Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that its network marketing division, Kannaway, has completed an Asset Purchase Agreement with eXfuse, LLC, dba KZ1 a Japan based network marketing company. The KZ1 acquisition will increase the sales force of the Company’s Kannaway division in Japan by approximately 1,450 individuals and the Company believes the increased sales force will greatly benefit Kannaway’s ramp up in the Japanese market. KZ1’s premium product "Focus," containing Nootropics, which helps support cognitive function, has been well received in the Japanese market and adds to the Company’s current line of CBD, natural health and beauty products.
Commenting on the acquisition, Kannaway President Bill Andreoli stated: "The combining of these two companies’ products and distributor genealogies will have an immediate positive effect on revenue in Japan. I am so excited for Kannaway and KZ1 distributors coming together with such a strong message of Hemp & Wellness."
Tim Scott, CEO said, "We have worked hard to increase financial efficiency and increase cash flow and the acquisition of KZ1 fits right into this strategy. With this acquisition, combining the KZ1 sales force with Kannaway’s, we expect to see a strong impact in Japan. This is just another step in our strategy to grow through acquisitions while providing premium Hemp and Wellness products to our customers worldwide."
Under the asset purchase agreement Kannaway acquired essentially all of KZ1’s operating assets for a purchase price of $5 million and will integrate the KZ1 and Kannaway sales forces. Closing of the transaction required cash of $150,000 and conditional obligations to KZ1 totaling $4,850,000, which are payable only from royalties and sales overrides on future sales of KZ1 products and are otherwise non-recourse obligations against either Kannaway or the Company.
ABOUT MEDICAL MARIJUANA, INC.
Medical Marijuana, Inc. (OTCMarkets: MJNA) manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products via e-commerce, direct sales, retail and wholesale distribution channels throughout the world. The Company operates primarily through three divisions: Medical Marijuana, Inc., HempMeds®, and Kannaway®.
Medical Marijuana, Inc.
Medical Marijuana, Inc. is the parent company of all operating divisions and operates a website to maintain an online presence, provide corporate, investor relations and educational information and news relating to the Company and its operations.
HempMeds®
HempMeds® distributes CBD products directly in the US and through wholly owned subsidiaries internationally (primarily in Mexico and Brazil). Distribution is accomplished via its online presence and its sales staff.
Kannaway®
Kannaway® is the Company’s direct selling division which started in 2014 and was the first Cannabis based direct selling company. Kannaway is the Company’s largest division and sells the Company’s Natural Health and CBD products worldwide, including, but not limited to the US, Europe, and Asia. In September 2022, Kannaway purchased the assets of Mfinity Global LLC, a direct-selling organization focused on promoting Natural Health products. The Mfinity products have now been added to the Kannaway line of products.
10/16/23 FINS CONFIRMS ERBB SELLING_2325_CYPRESS_PROPERTY AS SORBYTECH FOUND OUT & POSTED ON 9/18/23!!! https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172848918
PER PAGES 10 & 18 OF THEIR 10/16/23 AMERICAN GREEN, INC. FINANCIAL REPORT: https://www.otcmarkets.com/otcapi/company/financial-report/383816/content
“If we are able to negotiate the removal of the lien and refinance the property, we have received offers to purchase it above $5M.”
HOWEVER, THEY MAY JUST LOSE THE PROPERTY ON 10/31/23 IN FORECLOSURE:
“The Company is attempting to refinance its property located at 2325 W. Cypress Street in Phoenix. Currently, the mortgage is in default and its contractor has placed a mechanics lien of approximately $2.2M dollars. The Company disputes the amount of the lien and is currently attempting to negotiate a settlement with removal of the lien as the primary reason to entertain a settlement. If we are unsuccessful, in obtaining the refinance, which is dependent upon achieving the release of the lien, we may lose the property on October 31, 2023, in foreclosure.”
BASED ON ALL THIS NEW “OFFICIAL” COMPANY INFO ABOVE, I WOULD “ASSUME” ALL CONSTRUCTION ON CONVERSION OF THE BUILDING IS NOW STOPPED SO ANY NEW/RECENT “PERMITS ISSUED” ON THE BUILDING CONSTRUCTION DO NOT MATTER ANY LONGER!!! https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172990832
BASED ON THE ABOVE, (1) AMERICAN GREEN, INCs ENDEAVOR TO HAVE A "SECOND" AMERICAN GREEN MJ CULTIVATION FACILITY HAS FAILED AND (2) THEY SHOULD HAVE NEVER ATTEMPTED TO DO THIS MONEY-LOSING ENDEAVOR.
ALSO, SORBYTECH FOUND OUT & POSTED ON 8/15/23 OTHER ERBB INFO AS WELL SPECIFICALLY ERBB SELLING THEIR “VENDWEB” VENDING MACHINE BUSINESS CONFIRMED ON PAGE 7 OF THEIR 10/16/23 ERBB FINANCIAL REPORT: “The Company is negotiating the sale of VendWeb, LLC.”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172606352
ADDITIONAL ERBB “NEGATIVES” IN ERBBs 10/16/23 ERBB FINANCIAL REPORT BELOW:
1. “The Company is currently in the process of applying for a 100:1 reverse stock split.” (PAGE 2)
2. “The Company has been sued by a leasing company over approximately $900,000 in equipment for our Cypress facility. The Company is negotiating the sale of that equipment and hopes to settle the suit with the proceeds of this proposed sale”. (PAGES 10 & 18)
3. “The Company has been sued by Glorious Extracts over the termination of its rental of space at our Virginia Grow. WE believe that we had more than sufficient grounds to terminate their presence in our facility. Settlement discussions continue”. (PAGES 10 & 18)
ERBB SHOULD HAVE BEEN INFORMING/UPDATING/WARNING ERBB SHAREHOLDERS, POTENTIAL SHAREHOLDERS, AND OTHERS OF THEIR SERIOUS “NEGATIVE” ERBB UNEXPECTED “TURN OF EVENTS” FREQUENTLY IN PRs SINCE THEIR LAST PR OVER “EIGHT” MONTHS AGO ON 2/14/23 SO PEOPLE DO NOT (1) “ASSUME” THINGS ARE GOING AS PLANNED AND (2) GET A “BIG NEGATIVE SURPRISE” GETTING NOTIFIED IN THEIR AMERICAN GREEN, INC. FINANCIAL REPORT “EIGHT” MONTHS AFTER THEIR 2/14/23 PR!!!
ERBB STILL NEEDS TO ISSUE A PR NOTING AND EXPLAINING ALL THE ABOVE; ANY OTHER COMPANY CONCERNS; AND THE COMPANY’S FUTURE OUTLOOK!!! ERBB SHOULD HAVE ISSUED THEIR 10/16/23 FINANCIAL REPORT IN A PR!!!
>>>CHECK OUT SORBYTECH'S POSTS FOR ANY OF HIS ADDITIONAL ERBB DD/FINDINGS: https://investorshub.advfn.com/boards/profile.aspx?user=686285